Gastric floating matrix tablets: Design and optimization using combination of polymers

A. A. Deshpande, C. T. Rhodes, N. H. Shah, A. W. Malick, Controlled-release drug delivery systems for prolonged gastric residence: an overview, Drug. Dev. Ind. Pharm. 22 (1996) 631-539; DOI: 10.3109/03639049609063217.10.3109/03639049609063217Search in Google Scholar

S. J. Hwang, H. Park and K. Park, Gastric retentive drug-delivery systems, Crit. Rev. Ther. Drug. Carrier. Syst. 15 (1998) 243-283.Search in Google Scholar

A. A. Deshpande, N. H. Shah, C. T. Rhodes and A. W. Malick. Development of a novel controlled-release system for gastric retention, Pharm. Res. 14 (1997) 815-819; DOI: 10.1023/A:101217-1010492.Search in Google Scholar

S. S. Davis, A. F. Stockwell, M. J. Taylor, J. G. Hardy, D. R. Whalley, C. G. Wilson, H. Bechgaard and F. N. Christensen, The effect of density on the gastric emptying of single and multiple-unit dosage forms, Pharm. Res. 3 (1986) 208-213; DOI: 10.1023/A: 1016334629169.Search in Google Scholar

R. Groning and G. Heun, Dosage forms with controlled gastrointestinal passage-studies on the absorption of nitrofurantoin, Int. J. Pharm. 56 (1989) 111-116; DOI: 10.1016/0378-5173(89)90003-3.10.1016/0378-5173(89)90003-3Search in Google Scholar

A. Streubel, J. Siepmann and R. Bodmeier, Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release, Eur. J. Pharm. Sci. 18 (2003) 37-45; DOI: 10.1016/S0928-0987(02)00223-3.10.1016/S0928-0987(02)00223-3Search in Google Scholar

Martindale - The Extra Pharmacopoeia, 31^st ed., Pharmaceutical Press, London 1996, pp. 1217-1218.Search in Google Scholar

M. Albright Lisa, Use of domperidone as a prokinetic and antiemetic, health and wellness, Int. J. Pharm. Comp. 9 (2005) 120-125.Search in Google Scholar

B. Mehta, P. Doshi, M. Joshi and M. Dattat, Floating Osmotic Device for Controlled Release Drug Delivery, U.S. Pat. 9,92,897 3 March 2003.Search in Google Scholar

K. Naonori, H. Yatabe, K. Iseki and M. Katsumi, A new type of pH independent controlled release tablet, Int. J. Pharm. 68 (1991) 255-264; DOI: 10.1016/0378-5173(91)90147-G.10.1016/0378-5173(91)90147-GSearch in Google Scholar

K. Thomma and T. Zimmer, Retardation of weakly basic drug with diffusion tablet, Int. J. Pharm. 58 (1990) 197-202; DOI: 10.1016/0378-5173(90)90195-A.10.1016/0378-5173(90)90195-ASearch in Google Scholar

P. R. Sheth and J. L. Tossounian, Sustained Release Tablet Formulations, U.S. Pat. 4,140,755 2 Feb 1979.Search in Google Scholar

M. Rosa, H. Zia and T. Rhodes, Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. 105 (1994) 65-70; DOI: 10.1016/0378-5173(94)90236-4.10.1016/0378-5173(94)90236-4Search in Google Scholar

British Pharmacopoeia, HMSO, London 2000, pp. 732.Search in Google Scholar

N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.Search in Google Scholar

S. Li, S. Lin, Y. W. Chein, B. P. Daggy and H. L. Mirchandani, Statistical optimisation of gastric floating system for oral controlled delivery of calcium, AAPS Pharm. Sci. Tech. 2 (2001) article 1; http://www.pharmscitech.com. http://www.pharmscitech.com10.1208/pt020101Search in Google Scholar

S. Li, S. Lin, B. P. Daggy, H. L. Mirchandani and Y. W. Chein, Effect of HPMC and carbopol on the release and the floating properties of gastric floating drug delivery system using factorial design, Int. J. Pharm. 253 (2003) 13-22; DOI: 10.1016/S0378-5173(02)00642-7.10.1016/S0378-5173(02)00642-7Search in Google Scholar

F. Kedzierewicz, P. Thouvenot, J. Lemut, A. Etienne, M. Hoffman and P. Maincent, Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy, J. Control. Rel. 58 (1999) 195-205; DOI: 10.1016/S0168-3659(98)00154-0.10.1016/S0168-3659(98)00154-0Search in Google Scholar